Continuous Renal Replacement Therapy Crrt Market Scope And Analysis

Report Code : TIPHE100001251
Category : Life Sciences

No. of Pages : 150

Buy Now

Continuous Renal Replacement Therapy Market Analysis, Size, and Growth (2021-2022)

Buy Now

Continuous Renal Replacement Therapy Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 1.42 Billion
Market Size by 2030	US$ 2.75 Billion
Global CAGR (2022 - 2030)	8.7%
Historical Data	2020-2022
Forecast period	2022-2030
Segments Covered	By Product Dialysates and Replacement Fluids Disposables Hemofilters Bloodline Sets and Tubes CRRT Systems By Modality Continuous Venovenous Hemofiltration Continuous Venovenous Hemodiafiltration Continuous Venovenous Hemodialysis Slow Continuous Ultrafiltration By End User Hospitals Ambulatory Care Centers Homecare
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Baxter International Inc Asahi Kasei Fresenius Medical Care Medica S p A Medtronic Plc B Braun Nikkiso Co Ltd Toray Medical Co Ltd Infomed SA

Competitive Landscape and Key Companies:

The continuous renal replacement therapy market report is focused on prominent players in the market such as Baxter International Inc, Asahi Kasei, Fresenius Medical Care, Medica S.p.A., Medtronic Plc, B. Braun, Nikkiso Co Ltd, Toray Medical Co Ltd, Infomed SA, and Quanta Dialysis Technologies Inc. The continuous renal replacement therapy market forecast can help stakeholders plan their growth strategies. These companies focus on launching new technologies, upgrading existing products, and expanding their businesses to meet the growing consumer demand worldwide.

In April 2022, the US Food and Drug Administration (FDA) provided 510(k) clearance for the ST Set by Baxter International Inc. for its use in continuous renal replacement therapy (CRRT). The ST Set is a pre-connected, disposable, extracorporeal (outside the body) circuit that provides blood purification through a semipermeable membrane to be used with the PrisMax or Prismaflex control units (monitors).
In March 2022, Nipro Medical Corporation (Nipro), a leading manufacturer and supplier of renal, vascular, and medical-surgical products, announced the commercial launch of the SURDIAL DX Hemodialysis System in the US. SURDIAL DX is a state-of-the-art hemodialysis system designed to create an optimal dialysis treatment experience for patients and clinicians. Manufactured in Japan, the product is based is based on over 35 years of expertise in renal device innovation at Nipro’s parent company, Nipro Corporation.